| Item Type | Name |
|
Academic Article
|
Gene expression profiling to identify oncogenic determinants of autocrine human growth hormone in human mammary carcinoma.
|
|
Academic Article
|
Identifying gene expression changes in breast cancer that distinguish early and late relapse among uncured patients.
|
|
Academic Article
|
A modular analysis of breast cancer reveals a novel low-grade molecular signature in estrogen receptor-positive tumors.
|
|
Academic Article
|
Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study.
|
|
Academic Article
|
Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer.
|
|
Academic Article
|
CDKN1C (p57) is a direct target of EZH2 and suppressed by multiple epigenetic mechanisms in breast cancer cells.
|
|
Academic Article
|
Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer.
|
|
Academic Article
|
Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma.
|
|
Academic Article
|
Ferroportin and iron regulation in breast cancer progression and prognosis.
|
|
Academic Article
|
SOSTDC1 differentially modulates Smad and beta-catenin activation and is down-regulated in breast cancer.
|
|
Academic Article
|
An iron regulatory gene signature predicts outcome in breast cancer.
|
|
Academic Article
|
YB-1, the E2F pathway, and regulation of tumor cell growth.
|
|
Academic Article
|
Cyclin E2 overexpression is associated with endocrine resistance but not insensitivity to CDK2 inhibition in human breast cancer cells.
|
|
Academic Article
|
JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer.
|
|
Academic Article
|
Discovery of estrogen receptor alpha target genes and response elements in breast tumor cells.
|
|
Academic Article
|
An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival.
|
|
Academic Article
|
Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome.
|
|
Academic Article
|
Expression genomics in breast cancer research: microarrays at the crossroads of biology and medicine.
|
|
Academic Article
|
Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer.
|
|
Academic Article
|
A gene signature in breast cancer.
|
|
Academic Article
|
RCP is a human breast cancer-promoting gene with Ras-activating function.
|
|
Academic Article
|
CT-X antigen expression in human breast cancer.
|
|
Academic Article
|
Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinoma.
|
|
Academic Article
|
Combined genomic and phenotype screening reveals secretory factor SPINK1 as an invasion and survival factor associated with patient prognosis in breast cancer.
|
|
Academic Article
|
Yin Yang 1 contains G-quadruplex structures in its promoter and 5'-UTR and its expression is modulated by G4 resolvase 1.
|
|
Academic Article
|
Yin Yang 1 plays an essential role in breast cancer and negatively regulates p27.
|
|
Concept
|
Breast
|
|
Concept
|
Breast Neoplasms
|
|
Concept
|
Carcinoma, Ductal, Breast
|
|
Academic Article
|
The regulation of SOX7 and its tumor suppressive role in breast cancer.
|
|
Academic Article
|
Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis.
|
|
Academic Article
|
IRP2 regulates breast tumor growth.
|
|
Academic Article
|
DEAD-box helicase DP103 defines metastatic potential of human breast cancers.
|
|
Academic Article
|
Dual roles for immune metagenes in breast cancer prognosis and therapy prediction.
|
|
Academic Article
|
Prognostic value of the hDMP1-ARF-Hdm2-p53 pathway in breast cancer.
|
|
Academic Article
|
A phase II clinical trial of weekly paclitaxel and carboplatin in combination with panitumumab in metastatic triple negative breast cancer.
|
|
Academic Article
|
Systems biology approach to studying proliferation-dependent prognostic subnetworks in breast cancer.
|
|
Academic Article
|
Prognostic and predictive immune gene signatures in breast cancer.
|
|
Academic Article
|
EGFR and HER2 signaling in breast cancer brain metastasis.
|
|
Academic Article
|
ERRa Is a Marker of Tamoxifen Response and Survival in Triple-Negative Breast Cancer.
|
|
Academic Article
|
Effects of Pubertal Exposure to Dietary Soy on Estrogen Receptor Activity in the Breast of Cynomolgus Macaques.
|
|
Academic Article
|
Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness.
|
|
Academic Article
|
Yin Yang 1 promotes mTORC2-mediated AKT phosphorylation.
|
|
Academic Article
|
Multimodal Assessment of Estrogen Receptor mRNA Profiles to Quantify Estrogen Pathway Activity in Breast Tumors.
|
|
Academic Article
|
Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis.
|
|
Academic Article
|
Concordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifen.
|
|
Academic Article
|
A collection of annotated and harmonized human breast cancer transcriptome datasets, including immunologic classification.
|
|
Academic Article
|
Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014.
|
|
Academic Article
|
Tumor mutational burden is a determinant of immune-mediated survival in breast cancer.
|